CDSCO UID MFG/MD/2022/000072_07c7daf8920f14340a854b923ac4bed1_b360afd1020e9ecf6bd0b7d2b7e1412f

Uric Acid

DELTA LAB·Device Class Class B·India CDSCO·Brand: CRP
Registration details
UID
MFG/MD/2022/000072_07c7daf8920f14340a854b923ac4bed1_b360afd1020e9ecf6bd0b7d2b7e1412f
Device class
Class B
Brand name
CRP
License holder
DELTA LAB
Approving authority
Kokan Division
Product information
Reagent kit is intended for "in vitro" quantitative determination of Uric Acid concentration in serum & urine
Similar products (10)
Other products with the same name or brand
Microprotien
Brand: CRP
DELTA LAB
Class B
CHOLINESTERASE
Brand: CRP
DELTA LAB
Class B
Albumin
Brand: CRP
DELTA LAB
Class B
Phosphorus
Brand: CRP
DELTA LAB
Class B
Total Protein
Brand: CRP
DELTA LAB
Class B
Urea Nitrogen
Brand: CRP
DELTA LAB
Class B
LDL Cholesterol Direct
Brand: CRP
DELTA LAB
Class B
SODIUM
Brand: CRP
DELTA LAB
Class B
Lipase
Brand: CRP
DELTA LAB
Class B
G-6PDH
Brand: CRP
DELTA LAB
Class B
Other products from DELTA LAB
Products from the same license holder (10 products)
Microprotien
Brand: CRP
Class B
COAGULATION ANALYZER
Class A
CHOLINESTERASE
Brand: CRP
Class B
CRP LATEX
Class B
HbA1c
Class B
ASO TURBILATEX
Class B
Albumin
Brand: CRP
Class B
Phosphorus
Brand: CRP
Class B
Total Protein
Brand: CRP
Class B
WIDAL TUBE TEST
Class B
About this record

Uric Acid is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/MD/2022/000072_07c7daf8920f14340a854b923ac4bed1_b360afd1020e9ecf6bd0b7d2b7e1412f. This device is marketed under the brand name CRP. The license holder is DELTA LAB, and it is classified as Device Class Class B. The approving authority is Kokan Division.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.